Mogrify (private company)
See something wrong or missing? Let us know
Offices:Cambridge
Industry:BiotechHealth services
Business model:B2B
Mogrify is a biotechnology company that develops proprietary tailored cell conversions that power every cell therapy.
Investors:
we tracked 8 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 46.7M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Mogrify
| Name | Criteria | |
|---|---|---|
![]() |
Atai Life Sciences
67%
|
|
![]() |
Causaly
67%
|
|
![]() |
Leyden Labs
63%
|
|
![]() |
Xenothera
63%
|
|
![]() |
Sano Genetics
62%
|
|
![]() |
Clustermarket
62%
|
|
![]() |
Cinclus Pharma
60%
|
|
![]() |
Mentis Cura
60%
|
|
![]() |
Oncoinvent
60%
|
|
![]() |
Nanolyze
58%
|
|






Belgium
Austria
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Ireland
Italy
Portugal
Spain